• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Public Health . Transmissibility and pathogenicity of the severe acute respiratory syndrome coronavirus 2: A systematic review and meta-ana

tetano

Editor, Senior Moderator
J Infect Public Health


. 2022 Jan 31;15(3):297-306.
doi: 10.1016/j.jiph.2022.01.015. Online ahead of print.
Transmissibility and pathogenicity of the severe acute respiratory syndrome coronavirus 2: A systematic review and meta-analysis of secondary attack rate and asymptomatic infection


Naiyang Shi[SUP] 1 [/SUP], Jinxin Huang[SUP] 1 [/SUP], Jing Ai[SUP] 2 [/SUP], Qiang Wang[SUP] 1 [/SUP], Tingting Cui[SUP] 1 [/SUP], Liuqing Yang[SUP] 1 [/SUP], Hong Ji[SUP] 2 [/SUP], Changjun Bao[SUP] 2 [/SUP], Hui Jin[SUP] 3 [/SUP]



Affiliations

Abstract

Background: Understanding the transmissibility and pathogenicity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for control policies, but evidence remains limited.
Methods: We presented a systematic and meta-analytic summary concerning the transmissibility and pathogenicity of COVID-19.
Results: A total of 105 studies were identified, with 35042 infected cases and 897912 close contacts. 48.6% (51/105) of studies on secondary transmissions were from China. We estimated a total SIR of 7.8% (95% confidence interval [CI], 6.8%-8.8%), SAR of 6.6% (95% CI, 5.7%-7.5%), and symptomatic infection ratio of 86.9% (95%CI, 83.9%-89.9%) with a disease series interval of 5.84 (95%CI, 4.92-6.94) days. Household contacts had a higher risk of both symptomatic and asymptomatic infection, and transmission was driven between index cases and second-generation cases, with little transmission occurring in second-to-later-generation cases (SIR, 12.4% vs. 3.6%). The symptomatic infection ratio was not significantly different in terms of infection time, generation, type of contact, and index cases.
Conclusions: Our results suggest a higher risk of infection among household contacts. Transmissibility decreased with generations during the intervention. Pathogenicity of SARS-CoV-2 varied among territories, but didn't change over time. Strict isolation and medical observation measures should be implemented.

Keywords: Asymptomatic infections; COVID-19; Incidence; Meta-analysis; SARS-CoV-2; Virulence.
 
Back
Top Bottom